These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31772027)

  • 1. Crystal structure of the M
    Vuckovic Z; Gentry PR; Berizzi AE; Hirata K; Varghese S; Thompson G; van der Westhuizen ET; Burger WAC; Rahmani R; Valant C; Langmead CJ; Lindsley CW; Baell JB; Tobin AB; Sexton PM; Christopoulos A; Thal DM
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):26001-26007. PubMed ID: 31772027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and dynamics of the M3 muscarinic acetylcholine receptor.
    Kruse AC; Hu J; Pan AC; Arlow DH; Rosenbaum DM; Rosemond E; Green HF; Liu T; Chae PS; Dror RO; Shaw DE; Weis WI; Wess J; Kobilka BK
    Nature; 2012 Feb; 482(7386):552-6. PubMed ID: 22358844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors.
    Tränkle C; Dittmann A; Schulz U; Weyand O; Buller S; Jöhren K; Heller E; Birdsall NJ; Holzgrabe U; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2005 Dec; 68(6):1597-610. PubMed ID: 16157694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Novel Allosteric Site at the M
    Burger WAC; Gentry PR; Berizzi AE; Vuckovic Z; van der Westhuizen ET; Thompson G; Yeasmin M; Lindsley CW; Sexton PM; Langmead CJ; Tobin AB; Christopoulos A; Valant C; Thal DM
    ACS Chem Neurosci; 2021 Aug; 12(16):3112-3123. PubMed ID: 34351123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Characteristics of the Allosteric Binding Site Represent a Key to Subtype Selective Modulators of Muscarinic Acetylcholine Receptors.
    Bermudez M; Rakers C; Wolber G
    Mol Inform; 2015 Aug; 34(8):526-30. PubMed ID: 27490498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Conserved Tyrosine Lid Residues in the Activation of the M
    Pham V; Habben Jansen MCC; Thompson G; Heitman LH; Christopoulos A; Thal DM; Valant C
    Mol Pharmacol; 2023 Sep; 104(3):92-104. PubMed ID: 37348914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of Action of M5 Muscarinic Acetylcholine Receptor Allosteric Modulators.
    Berizzi AE; Gentry PR; Rueda P; Den Hoedt S; Sexton PM; Langmead CJ; Christopoulos A
    Mol Pharmacol; 2016 Oct; 90(4):427-36. PubMed ID: 27461343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Features of Iperoxo-BQCA Muscarinic Acetylcholine Receptor Hybrid Ligands Determining Subtype Selectivity and Efficacy.
    Wakeham MCL; Davie BJ; Chalmers DK; Christopoulos A; Capuano B; Valant C; Scammells PJ
    ACS Chem Neurosci; 2022 Jan; 13(1):97-111. PubMed ID: 34905693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structures of the M1 and M4 muscarinic acetylcholine receptors.
    Thal DM; Sun B; Feng D; Nawaratne V; Leach K; Felder CC; Bures MG; Evans DA; Weis WI; Bachhawat P; Kobilka TS; Sexton PM; Kobilka BK; Christopoulos A
    Nature; 2016 Mar; 531(7594):335-40. PubMed ID: 26958838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
    Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel allosteric effects of amiodarone at the muscarinic M5 receptor.
    Stahl E; Ellis J
    J Pharmacol Exp Ther; 2010 Jul; 334(1):214-22. PubMed ID: 20348203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Muscarinic Acetylcholine Receptor M
    Bender AM; Garrison AT; Lindsley CW
    ACS Chem Neurosci; 2019 Mar; 10(3):1025-1034. PubMed ID: 30280567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
    Miyoshi S; Tu AT
    Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of selective positive allosteric modulators of antagonists for the M
    Korczynska M; Clark MJ; Valant C; Xu J; Moo EV; Albold S; Weiss DR; Torosyan H; Huang W; Kruse AC; Lyda BR; May LT; Baltos JA; Sexton PM; Kobilka BK; Christopoulos A; Shoichet BK; Sunahara RK
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2419-E2428. PubMed ID: 29453275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
    Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
    J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.